AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Investor AB

Interim / Quarterly Report Jul 17, 2023

2931_ir_2023-07-17_04b2a9f4-717e-4cdf-8606-7695c58235f8.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

Interim Report

January-June 2023

"Investor performed strongly during the second quarter. Our subsidiaries within Patricia Industries reported double-digit organic sales growth and sharply rising profits. In the current complex environment with a continued uncertain macroeconomic outlook, ensuring high flexibility and the ability to respond swiftly to rapid changes remains imperative."

Johan Forssell, President & CEO of Investor

Highlights during the second quarter

  • Adjusted net asset value (NAV) amounted to SEK 773,060m (SEK 252 per share) on June 30, 2023, an increase of SEK 62,916m, or 9 percent, with dividend added back, during the quarter. Total shareholder return amounted to 6 percent, compared to 2 percent for the SIXRX return index.
  • Listed Companies generated a total return of 9 percent. Shares in Accelleron were divested for a total SEK 943 m.
  • Based on estimated market values, the total return for Patricia Industries, excluding cash, amounted to 11 percent (10 percent including cash), mainly driven by strong earnings growth, followed by positive currency impact. Multiple expansion and cash flow also impacted positively, but to a lesser extent.
  • Within Patricia Industries, sales growth for the major subsidiaries amounted to 22 percent, of which 13 percent organically in constant currency. Reported EBITA grew 40 percent and adjusted EBITA grew 34 percent.
  • Mölnlycke reported organic sales growth of 6 percent in constant currency. The EBITA margin improved.
  • The value change of Investments in EQT was 3 percent. Net cash flow to Investor amounted to SEK 536m.
  • Leverage was 1.7 percent as of June 30, 2023 (1.5 percent as of December 31, 2022). Gross cash amounted to SEK 27,491m and the average maturity of Investor AB's debt portfolio was 11.3 years on June 30, 2023.
Financial information*
6/30 2023 3/31 2023 12/31 2022
Adjusted NAV, SEK m* 773,060 723,621 673,250
Adjusted NAV, SEK per share* 252 236 220
Reported NAV, SEK m*1) 674,068 638,142 604,865
Reported NAV, SEK per share*1) 220 208 197
Market capitalization (both share classes), excluding repurchased shares, SEK m 660,496 637,575 584,163
Share price (B-share), SEK 215.65 206.05 188.56
Q2 2023 H1 2023
Adjusted NAV, sequential change, incl. dividend added back, SEK m* 62,916 113,288
Adjusted NAV, sequential change, incl. dividend added back, %* 9 17
Reported NAV, sequential change, incl. dividend added back, SEK m*1) 49,403 82,680
Reported NAV, sequential change, incl. dividend added back, %*1) 8 14
Market capitalization, sequential change, incl. dividend added back, SEK m* 33,030 86,441
Market capitalization, sequential change, incl. dividend added back, %* 5 15
Q2 2023 Q2 2022 H1 2023 H1 2022
Consolidated net sales, SEK m 14,831 12,280 28,841 23,929
Consolidated profit/loss, SEK m 45,309 -65,521 78,121 -134,646
Basic earnings per share, SEK 14.80 -21.38 25.53 -43.93

* Financial measures that are not defined or specified in the applicable financial reporting framework. For more information, see page 18 and 31-32. Change in market capitalization with dividend added back reflects the change in total market capitalization with the dividend paid out added back. Change in net asset value with dividend added back includes the full dividend approved by the AGM.

1) In the reported net asset value, the wholly-owned subsidiaries and partner-owned investments within Patricia Industries are reported according to the acquisition and equity method respectively. Methods are further described in Investor AB's Annual Report.

Overview annual average performance

YTD 1 year 5 years 10 years 20 years
Adjusted NAV incl. dividend added back, % 16.8 28.8 16.5
Investor B, total return, % 16.1 30.9 21.5 20.0 17.7
SIXRX return index, % 11.3 19.3 11.3 12.3 12.4

CEO statement

Dear fellow shareholders,

In the second quarter we delivered the highest adjusted net asset value ever, and Patricia Industries' profit reached a new record level. Our adjusted net asset value growth and total shareholder return amounted to 9 and 6 percent respectively, both outperforming the SIXRX return index that gained 2 percent. Our subsidiaries within Patricia Industries reported double-digit

organic sales growth and sharply rising profits. Also, after a few weaker quarters, cash conversion returned to healthier levels.

The macro outlook remains uncertain. Lingering inflation, prompting central banks to further rate hikes, continues to weigh on consumers. The geopolitical situation is complex and in China, the pace of the post pandemic recovery adds further uncertainty. On a positive note, supply chain constraints continue to ease, and significant investments are made to capitalize on opportunities related to climate change and digitalization. We also see increased capex in certain industries due to the geopolitical situation and the need to increase resilience by investing more regionally. In this complex and fast moving environment, ensuring high flexibility and the ability to respond swiftly to rapid changes in demand remains imperative for our companies.

Listed Companies

Listed Companies generated a total return of 9 percent during the quarter, primarily driven by Atlas Copco and ABB. Several of our companies took strategic actions to expand their customer offerings. Nasdaq expanded its position as a leading technology provider to the financial markets through the acquisition of Adenza. Through the acquisition of AirPlus, SEB will become a European leader within corporate payment solutions, and Sobi completed its acquisition of CTI Biopharma, broadening its product portfolio within hematology. As communicated, we will subscribe for our pro rata share in the rights issue that will partly finance the transaction.

We divested nearly 30 percent of our holding in the Swiss company Accelleron, spun off from ABB, for total proceeds of approximately SEK 1bn.

Patricia Industries

Based on estimated market values, Patricia Industries' total return, excluding cash, amounted to 11 percent during the quarter, mainly driven by strong earnings growth, followed by positive currency impact. Multiple expansion and cash flow also impacted positively, but to a lesser extent. Sales growth for the major subsidiaries amounted to 22 percent, of which 13 percent organic in constant currency. Adjusted EBITA growth was strong at 34 percent. Looking into the second half of 2023, it is worth remembering that the third quarter 2022 was strong, while the fourth quarter was relatively weaker. This will impact the year-over-year comparison for these two quarters.

Mölnlycke reported organic sales growth of 6 percent in constant currency, driven by continued strong performance in Wound Care and Operating Room Solutions. The operating margin improved and cash conversion strengthened significantly compared to last year.

All other subsidiaries except for Advanced Instruments and Atlas Antibodies grew organically, led by BraunAbility, Sarnova and Permobil. Subdued demand from the biopharma segment continued to impact Atlas Antibodies and Advanced Instruments.

During the quarter, Vectura announced the divestment of its Community Service portfolio, primarily consisting of elderly care properties. This is in line with the company's new strategic focus on developing real estate for innovation clusters, which also offers synergies with several of our portfolio companies, including AstraZeneca and Mölnlycke. We are pleased that Vectura has found a great new home for these high-quality properties, realizing an annual return on investment of approximately 15 percent during its ownership.

Investments in EQT

The total return on Investments in EQT amounted to 3 percent during the second quarter, driven by our fund investments. Net cash flow to Investor amounted to SEK 0.5bn. In May, EQT launched Nexus, broadening its investor base by offering individuals access to its different investment strategies.

Going forward

Our industry-leading companies, with strong profitability and cash flow generation, as well as high exposure to secular growth, form the basis for our long-term value creation. As an engaged owner, we continue to drive initiatives to ensure long-term competitiveness. Embracing new technology is clearly a strategic priority. Undoubtedly, AI will impact all businesses. Progress is rapid and our companies are launching many activities. We are currently running deep-dive analysis and education programs to gain improved understanding of the opportunities which AI brings in our prioritized industries and portfolio companies.

At the end of the quarter, our leverage was 2 percent, at the low end of our 0-10 percent target range. In combination with our strong cash flow generation, this provides us with significant financial capacity to support our companies and invest in all three business areas, based on where we find the most value-creating opportunities.

With our well-proven business model, strong portfolio of companies, clear strategic direction and financial strength, I remain confident in our ability to continue to grow net asset value. This is what ultimately will drive attractive total returns to you, dear fellow shareholders.

Johan Forssell President & CEO

Net asset value overview

Adjusted values Reported values
Number of Ownership Share of total Value, Value, Value, Value,
shares capital/votes (%) assets (%) SEK m SEK m SEK m SEK m
6/30 2023 6/30 2023 6/30 2023 6/30 2023 12/31 2022 6/30 2023 12/31 2022
Listed Companies
Atlas Copco
835,653,755 17.0/22.3 16 128,457 102,091 128,457 102,091
ABB 265,385,142 14.1/14.1 14 112,356 83,944 112,356 83,944
AstraZeneca 51,587,810 3.3/3.3 10 79,806 72,403 79,806 72,403
SEB 456,198,927 21.3/21.4 7 54,381 54,646 54,381 54,646
Epiroc 207,635,622 17.1/22.7 5 42,013 39,075 42,013 39,075
Nasdaq 58,182,426 11.9/11.9 4 31,459 37,249 31,459 37,249
Saab 40,972,622 30.2/39.7 3 23,862 16,852 23,862 16,852
Sobi 107,594,165 34.6/34.6 3 22,571 23,270 22,571 23,270
Ericsson 266,745,735 8.0/23.7 2 15,935 16,849 15,935 16,849
Wärtsilä 104,711,363 17.7/17.7 2 12,741 9,196 12,741 9,196
Husqvarna 97,052,157 16.8/33.4 1 9,456 7,122 9,456 7,122
Electrolux 50,786,412 17.9/30.4 1 7,477 7,151 7,477 7,151
Electrolux Professional 58,941,654 20.5/32.5 0 3,416 2,579 3,416 2,579
Accelleron 9,671,926 10.2/10.2 0 2,499 2,868 2,499 2,868
Total Listed Companies 69 546,431 475,296 546,431 475,296
Patricia Industries Total exposure (%)
Subsidiaries
Mölnlycke1) 99 10 77,479 58,888 21,983 18,780
Laborie 98 3 20,411 15,991 9,645 9,580
Sarnova 95 2 16,142 12,674 8,333 8,029
Permobil1) 98 2 15,206 11,651 4,937 5,211
Advanced Instruments 98 1 10,957 10,073 8,893 8,575
Piab1) 97 1 9,295 7,869 6,411 6,189
BraunAbility 93 1 8,632 5,222 2,538 2,388
Vectura 99 0 3,766 3,845 4,040 3,821
Atlas Antibodies 93 0 2,898 2,807 3,084 2,853
Total subsidiaries 21 164,785 129,019 69,863 65,424
Three Scandinavia 40/40 1 6,953 7,504 2,882 2,714
Financial Investments 0 1,737 1,972 1,737 1,972
Total Patricia Industries excl. cash 22 173,475 138,495 74,482 70,110
Total Patricia Industries incl. cash 185,005 150,317 86,013 81,933
Investments in EQT
EQT AB 174,288,016 14.7/14.7 5 36,200 38,500 36,200 38,500
Fund investments 4 33,793 31,550 33,793 31,550
Total Investments in EQT 9 69,992 70,050 69,992 70,050
Other Assets and Liabilities2) 0 -3,620 -328 -3,620 -328
Total Assets excl. cash Patricia Industries 100 786,278 683,513 687,285 615,128
Gross debt* -40,708 -38,796 -40,708 -38,796
Gross cash* 27,491 28,533 27,491 28,533
Of which Patricia Industries 11,530 11,823 11,530 11,823
Net debt -13,218 -10,263 -13,218 -10,263
Net Asset Value 773,060 673,250 674,068 604,865
Net Asset Value per share 252 220 220 197

1) Including receivables related to Management Participation Program foundations. For Mölnlycke, the receivable corresponds to less than 1 percentage point of the total exposure, for Permobil to approximately 2 percentage points and for Piab to approximately 3 percentage points.

2) As per 6/30 2023, including liability for dividend to shareholders of SEK 3,369m to be paid in November 2023.

Overview

For balance sheet items, figures in parentheses refer to year-end 2022 figures. For income statement and cash flow items, they refer to the same period last year.

Net asset value

During the first half of 2023, adjusted net asset value increased from SEK 673.2bn to SEK 773.1bn. The change in adjusted net asset value, with dividend added back, was 17 percent during the period (-18), of which 9 percent during the second quarter (-9).

Reported net asset value increased from SEK 604.9bn to SEK 674.1bn. The change in reported net asset value, with dividend added back, was 14 percent during the period (-19), of which 8 percent during the second quarter (-10).

Total adjusted assets by business area

Net debt and cash flow

Net debt totaled SEK 13,218m on June 30, 2023 (10,263), corresponding to leverage of 1.7 percent (1.5).

Our target leverage range is 0-10 percent (net debt/total adjusted assets) over a business cycle. While leverage can fluctuate above and below the target level, it should not exceed 20 percent for a longer period of time.

Gross cash amounted to SEK 27,491m and gross debt to SEK 40,708m as of June 30, 2023. The average maturity of Investor AB's debt portfolio was 11.3 years on June 30, 2023 (11.8).

Investor's net debt

SEK m H1 2023
Opening net debt -10,263
Listed Companies
Dividends 9,165
Divestments 914
Other capital distributions 46
Investments, net of proceeds -1
Management cost -79
Total 10,045
Patricia Industries
Proceeds 465
Investments -742
Management cost -157
Other1) 142
Total -292
Investments in EQT
Proceeds (divestitures, fee surplus and carry) 2,438
Drawdowns (investments and management fees) -2,304
Management cost -5
Total 128
Investor groupwide
Dividend to shareholders -10,109
Management cost -74
Other2) -2,654
Closing net debt -13,218

1) Incl. currency related effects and net interest paid.

2) Incl. currency related effects, revaluation of debt and net interest paid.

Management cost

Investor's management cost amounted to SEK 316m during the first half of 2023 (285), of which SEK 162m during the second quarter (152).

As of June 30, 2023, rolling 12-month management cost amounted to 0.08 percent of the adjusted net asset value.

The Investor share

The price of the Investor A-share and B-share was SEK 215.70 and SEK 215.65 respectively on June 30, 2023, compared to SEK 193.85 and SEK 188.56 on December 31, 2022.

The total shareholder return (Class B-share) amounted to 16 percent during the first half of 2023 (-25), of which 6 percent during the second quarter (-17).

The SIXRX return index was 11 percent during the first half of 2023 (-28), of which 2 percent during the second quarter (-16).

Investor's market capitalization, excluding repurchased shares, was SEK 660,496m as of June 30, 2023 (584,163).

Listed Companies

Listed Companies include ABB, Accelleron, AstraZeneca, Atlas Copco, Electrolux, Electrolux Professional, Epiroc, Ericsson, Husqvarna, Nasdaq, Saab, SEB, Sobi and Wärtsilä. These are multinational companies with strong market positions and proven track records.

Highlights during the quarter

  • Total return amounted to 9 percent, compared to 2 percent for the SIXRX return index.
  • We decreased our ownership in Accelleron.

Performance

Total return (excluding management costs) amounted to 17 percent during the first half of 2023, of which 9 percent during the second quarter.

The SIXRX return index was 11 percent during the first half of 2023, of which 2 percent during the second quarter.

Contribution to net asset value (adjusted and reported) amounted to SEK 81,209m during the first half of 2023 (-88,076), of which SEK 45,649m during the second quarter (-36,822).

Contribution to net asset value SEK m Q2 2023 H1 2023 H1 2022

Total 45,649 81,209 -88,076
Management cost -40 -79 -69
Dividends 4,953 9,165 8,207
Changes in value 40,736 72,123 -96,214

Contribution to net asset value and total return

Q2 2023 H1 2023
Value,
SEK m
Contribution,
SEK m
Total
return
(%)1)
Contribution,
SEK m
Total
return
(%)1)
Atlas Copco 128,457 19,895 18.2 27,361 26.8
ABB 112,356 17,907 19.0 30,925 37.6
AstraZeneca 79,806 5,314 7.1 8,470 11.8
SEB 54,381 5,131 10.5 2,814 5.8
Epiroc 42,013 -182 -0.4 3,304 8.5
Nasdaq 31,459 -1,332 -4.1 -5,542 -14.9
Saab 23,862 -1,791 -7.0 7,228 42.8
Sobi 22,571 -3,377 -13.0 -699 -3.0
Ericsson 15,935 -870 -5.2 -554 -3.4
Wärtsilä 12,741 2,490 24.3 3,699 40.7
Husqvarna 9,456 858 10.0 2,431 34.3
Electrolux 7,477 1,104 17.3 326 4.6
Electrolux
Professional
3,416 276 8.7 878 34.1
Accelleron 2,499 266 8.1 646 22.5
Total 546,431 45,689 9.1 81,288 17.4

1) Calculated as the sum of share price changes with reinvested dividends, including add-on investments and/or divestments.

Dividends received

Dividends received totaled SEK 9,165m during the first half of 2023 (8,207), of which SEK 4,953m during the second quarter (1,537).

Dividends received, Listed Companies

Investments and divestments

During the second quarter 2023 3,597,331 Accelleron shares were sold for SEK 943m. Atlas Copco's chairperson exercised all options, sold by Investor in 2019, and bought 477,380 A-shares for a consideration of SEK 39m. New 5-year options, with a strike price of 110 percent of the share price, were sold to the chairperson in Atlas Copco for a total consideration of SEK 5m.

During the first quarter 2023, Epiroc's chairperson exercised all options, sold by Investor in 2019, and bought shares for a consideration of SEK 15m. New 5-year options, with a strike price of 110 percent of the share price, were sold to the chairperson in Epiroc for a total consideration of SEK 2m.

Patricia Industries

Patricia Industries develops wholly-owned companies in the Nordics and in North America. Holdings include Advanced Instruments, Atlas Antibodies, BraunAbility, Laborie, Mölnlycke, Permobil, Piab, Sarnova, Vectura, Three Scandinavia and Financial Investments.

Highlights during the quarter

  • The major subsidiaries reported strong sales and profit growth.
  • Vectura announced the strategic divestment of its elderly care properties.

Operating performance

During the first half of 2023, sales growth for the major subsidiaries was 22 percent. Organic growth was 12 percent in constant currency. EBITA amounted to SEK 5,707m, an increase of 37 percent. Adjusting for items affecting comparability, EBITA grew by 34 percent.

During the second quarter 2023, sales growth amounted to 22 percent. Organic growth was 13 percent in constant currency. EBITA amounted to SEK 2,982m, an increase of 40 percent. Adjusted EBITA grew by 34 percent.

As of June 30, 2023, on a rolling 12-month basis, the companies' (subsidiaries and 40 percent of Three Scandinavia) combined sales and EBITDA amounted to SEK 59.6bn and SEK 14.0bn respectively. The corresponding figures as of March 31, 2023 were SEK 56.9bn and SEK 13.0bn respectively. During the second quarter 2023, sales and EBITDA amounted to SEK 15.6bn (12.9), and SEK 3.8bn (2.9) respectively.

Patricia Industries, adjusted values, June 30, 2023

Reported EBITDA (subsidiaries & 40% of Three Scandinavia)

Major subsidiaries, performance

Q2 2023

Org. growth,
constant
Operating
SEK m Sales currency EBITDA EBITDA (%) EBITA1) EBITA, (%) cash flow
Mölnlycke 5,442 6 1,546 28.4 1,362 25.0 1,275
Laborie 939 2 308 32.8 292 31.1 123
Sarnova 2,600 17 420 16.2 369 14.2 383
Permobil 1,407 13 281 20.0 230 16.3 201
Advanced Instruments 393 -1 168 42.7 160 40.7 164
Piab 789 4 222 28.2 193 24.5 199
BraunAbility 3,025 36 390 12.9 337 11.1 248
Vectura 82 9 41 49.5 4 4.7 -347
Atlas Antibodies 108 -6 43 40.0 36 32.9 36
Total 14,785 3,418 23.1 2,982 20.2 2,281
Reported growth y/y, % 22 36 40
Organic growth, y/y, % 13

H1 2023

Org. growth,
constant
Operating
SEK m Sales currency EBITDA EBITDA (%) EBITA1) EBITA, (%) cash flow
Mölnlycke 10,810 9 3,065 28.4 2,702 25.0 1,880
Laborie 1,812 5 564 31.1 532 29.3 358
Sarnova 5,148 14 770 15.0 670 13.0 822
Permobil 2,720 11 517 19.0 414 15.2 379
Advanced Instruments 745 -5 294 39.5 280 37.5 238
Piab 1,509 8 428 28.3 374 24.8 314
BraunAbility 5,634 23 732 13.0 626 11.1 251
Vectura 166 11 96 57.7 27 16.4 -699
Atlas Antibodies 219 1 97 44.3 82 37.4 64
Total 28,762 6,563 22.8 5,707 19.8 3,607
Reported growth y/y, % 22 34 37
Organic growth, y/y, % 12

1) EBITA is defined as operating profit before acquisition-related amortizations.

Value development

Contribution to adjusted net asset value amounted to SEK 34,538m during the first half of 2023 (-4,829), of which SEK 16,671m during the second quarter (2,468).

Contribution to adjusted net asset value

SEK m Q2 2023 H1 2023 H1 2022
Changes in value 16,761 34,704 -4,686
Management cost -80 -157 -149
Other -10 -9 6
Total 16,671 34,538 -4,829

Based on estimated market values, the total return for Patricia Industries, excluding cash, amounted to 25 percent (23 percent including cash) during the first half of 2023, of which 11 percent (10 percent including cash) during the second quarter. The positive return during the second quarter was mainly driven by strong earnings growth, followed by positive currency impact. Multiple expansion and cash flow also impacted positively, but to a lesser extent.

For more information on valuation, see page 35.

Investments and divestments

During the first half of 2023, investments amounted to SEK 742m, of which SEK 508m during the second quarter, mainly relating to Vectura.

Divestments amounted to SEK 70m during the the first half of 2023, of which SEK 5m during the second quarter.

Distributions received

During the first half of 2023, distributions to Patricia Industries amounted to SEK 395m (mainly related to distribution from Permobil), of which SEK 2m during the second quarter.

Distribution to Patricia Industries

Patricia Industries, net cash

SEK m Q2 2023 H1 2023 H1 2022
Beginning of period 12,017 11,823 12,505
Net cash flow -501 -277 -1,937
Internal transfer to Investor - - -3,124
Other1) 14 -16 -105
End of period 11,530 11,530 7,340

1) Includes currency-related effects, net interest and management cost.

Patricia Industries – valuation overview
Estimated market
values, SEK m,
6/30, 2023
Change Q2
2023 vs. Q1
2023 SEK m
Major drivers Comments
Subsidiaries
Mölnlycke 77,479 8,838 Currency, multiples, earnings and cash
flow impacted positively
Applied EV/reported LTM EBITDA 15.9x
Laborie 20,411 1,636 Currency and earnings impacted
positively
Applied EV/adjusted LTM EBITDA 19.0x
Sarnova 16,142 2,502 Earnings and currency impacted
positively
Applied EV/adjusted LTM EBITDA 14.3x
Permobil 15,206 1,782 Earnings and multiples impacted
positively
Applied EV/reported LTM EBITDA 15.8x
Advanced Instruments 10,957 218 Currency impacted positively, multiples
impacted negatively
Applied EV/adjusted LTM EBITDA 19.5x.
Acquisitions of Solentim and Artel valued at
cost
Piab 9,295 8 Earnings impacted positively, multiples
impacted negatively
Applied EV/adjusted LTM EBITDA 15.8x
BraunAbility 8,632 2,228 Earnings impacted positively Applied EV/adjusted LTM EBITDA 10.5x
Vectura 3,766 14 SEK 0.4bn contribution from Patricia
Industries, value impacted by taxes and
transaction costs related to the
divestment of elderly care properties
Estimated market value of the property
portfolio less debt and cost
Atlas Antibodies 2,898 -30 No major drivers Applied EV/adjusted LTM EBITDA 17.6x
Partner-owned
investments
Three Scandinavia 6,953 171 Earnings impacted positively Applied EV/adjusted LTM EBITDA 6.3x
Financial Investments 1,737 -106 Multiple or third-party valuation, share price
Total 173,475
Total incl. cash 185,005

A provider of single-use products and solutions for managing wounds, improving surgical safety and efficiency, and preventing pressure ulcers. Read more at www.molnlycke.com

Activities during the quarter

Group

  • Organic sales growth amounted to 6 percent in constant currency, driven by Wound Care and ORS.
  • The EBITA margin increased, driven by sales growth and lower logistics costs, partially offset by higher OPEX and negative currency impact.
  • Cash conversion improved significantly compared to last year.

Wound Care

  • Organic sales growth amounted to 8 percent in constant currency, with strong underlying demand in all regions, with APAC showing the strongest growth.
  • To further support growth, investments are made in the key factory in Mikkeli, Finland. In addition, investments will be made in localized China manufacturing.

Operating Room Solutions

• Organic sales growth amounted to 10 percent in constant currency, benefitting from increased elective surgery activity, price increases and improved product mix. From a product perspective, growth was mainly driven by Trays.

Gloves

• Organic sales growth amounted to -6 percent in constant currency. The decline was mainly related to the US market where distributors are reducing excess inventory built up during second half of 2022.

Antiseptics

• Organic sales growth amounted to -5 percent in constant currency. The US showed stable growth, while supply chain challenges remain in EMEA.

Mölnlycke, sales and margin development

Key figures, Mölnlycke

2023 2022
Income statement items,
EUR m
Q2 H1 Q2 H1 Last 12
months
Sales 475 955 459 885 1,898
EBITDA 135 271 125 237 510
EBITA 119 239 108 204 445
Sales growth, % 4 8 10 3
Organic growth,
constant currency, %
6 9 5 -1
EBITDA, % 28.4 28.4 27.2 26.8 26.9
EBITA, % 25.0 25.0 23.6 23.1 23.4
Cash flow items, EUR m Q2 H1 Q2 H1
EBITDA 135 271 125 237
Lease payments -6 -12 -5 -11
Change in working capital -7 -71 -30 -95
Capital expenditures -10 -22 -18 -30
Operating cash flow 112 166 73 101
Acquisitions/divestments - 0 - -
Shareholder
contribution/distribution
- - - -
Other1) -20 -36 -28 -68
Increase(-)/decrease(+) in net
debt
92 129 44 33
Key ratios
Working capital/sales, % 19
Capital expenditures/sales, % 3
Balance sheet items, EUR m 6/30 2023 12/31 2022
Net debt 1,492 1,621
6/30 2023 6/30 2022
Number of employees 8,705 8,625
1) Includes effects of exchange rate changes, interest, tax and change in lease

liabilities.

Mölnlycke, distribution of sales and organic sales growth

Share of sales, (%)
Last 12 months
Organic growth,
constant currency, (%)
Q2 2023
Wound Care 58 8
Operating Room
Solutions
25 10
Gloves 13 -6
Antiseptics 3 -5
Total 100 6

Mölnlycke, distribution of sales by geography

Share of sales, (%)
2022
Europe, Middle East, Africa 56
Americas 35
Asia Pacific 9
Total 100

A provider of diagnostic and therapeutic products within Gastroenterology, Urology & Urogynecology, and Obstetrics, Gynecology & Neonatal. Read more at www.laborie.com

Activities during the quarter

  • Organic sales growth amounted to 2 percent in constant currency. Growth was driven by the GI (Gastrointestinal) business and the OptilumeTM urethral strictures product, which continued to see strong commercial uptake. Within UR (Urology), capital equipment sales was negatively affected by continued supply chain constraints.
  • The EBITA margin increased, driven by operating leverage and favorable product mix, partly offset by continued significant investments in R&D.

Key figures, Laborie

Income statement items, 2023 2022 Last 12
USD m Q2 H1 Q2 H1 months
Sales 89 173 87 166 346
EBITDA 29 54 23 42 109
EBITA 28 51 22 38 103
Sales growth, % 2 4 9 6
Organic growth, 2 5 9 7
constant currency, %
EBITDA, % 32.8 31.1 26.8 25.1 31.6
EBITA, % 31.1 29.3 25.0 23.1 29.7
Cash flow items, USD m Q2 H1 Q2 H1
EBITDA 29 54 23 42
Lease payments -1 -1 -1 -1
Change in working capital -14 -13 -8 -23
Capital expenditures -3 -6 -2 -3
Operating cash flow 12 34 13 15
Acquisitions/divestments - -3 -27 -167
Shareholder - - - 100
contribution/distribution
Other1) -6 -16 -6 2
Increase(-)/decrease(+) in net
debt
5 15 -20 -51
Key ratios
Working capital/sales, % 21
Capital expenditures/sales, % 3
Balance sheet items, USD m 6/30 2023 12/31 2022
Net debt 439 454
6/30 2023 6/30 2022
Number of employees 905 885

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A US provider of specialty healthcare and safety products, services and software for the US emergency medical services (EMS), acute care and cardiac response markets. Read more at www.sarnova.com

Activities during the quarter

  • Organic sales grew by 17 percent in constant currency. All segments grew, with the strongest growth in Cardiac Response, which benefitted from strong demand and recovery from the prior quarters' supply chain challenges related to the availability of Automated External Defibrillators (AEDs).
  • The EBITA margin increased, driven by good operating performance offset by investments in the commercial organization, digital platform enhancement and warehouse optimization.

Key figures, Sarnova

Income statement items, 2023 2022 Last 12
USD m Q2 H1 Q2 H1 months
Sales 247 492 211 432 976
EBITDA 40 74 28 59 150
EBITA 35 64 24 50 132
Sales growth, % 17 14 15 16
Organic growth,
constant currency, %
17 14 6 4
EBITDA, % 16.2 15.0 13.4 13.5 15.4
EBITA, % 14.2 13.0 11.5 11.6 13.5
Cash flow items, USD m Q2 H1 Q2 H1
EBITDA 40 74 28 59
Lease payments -1 -2 -1 -2
Change in working capital 1 14 0 12
Capital expenditures -4 -7 -7 -11
Operating cash flow 36 78 20 58
Acquisitions/divestments - - - -
Shareholder - - - -
contribution/distribution
Other1) -20 -32 -20 -27
Increase(-)/decrease(+) in net
debt
16 46 0 31
Key ratios
Working capital/sales, % 14
Capital expenditures/sales, % 1
Balance sheet items, USD m 6/30 2023 12/31 2022
Net debt 480 526
6/30 2023 6/30 2022
Number of employees 1,405 1,360

A provider of advanced mobility and seating rehab solutions, including powered and manual wheelchairs, pressure-relieving cushions and powerassist devices. Read more at www.permobil.com

Activities during the quarter

  • Organic sales growth amounted to 13 percent in constant currency, supported by all regions. Aftermarket services, which is a prioritized area for Permobil, continued to report high growth.
  • The EBITA margin increased driven by operating leverage and improved supply chain.
  • Permobil introduced the M Corpus VS, an innovative midwheel driven standing power wheelchair with unique maneuverability combined with the standing function.

Key figures, Permobil

Income statement items, 2023 2022 Last 12
SEK m Q2 H1 Q2 H1 months
Sales 1,407 2,720 1,177 2,293 5,676
EBITDA 281 517 187 364 1,223
EBITA 230 414 145 278 1,016
Sales growth, % 20 19 20 21
Organic growth, 13 11 0 3
constant currency, %
EBITDA, % 20.0 19.0 15.9 15.9 21.5
EBITA, % 16.3 15.2 12.3 12.1 17.9
Cash flow items, SEK m Q2 H1 Q2 H1
EBITDA 281 517 187 364
Lease payments -20 -40 -15 -31
Change in working capital 12 42 -49 -169
Capital expenditures -72 -141 -110 -164
Operating cash flow 201 379 13 0
Acquisitions/divestments - - - -280
Shareholder - -400 - 350
contribution/distribution
Other1) -326 -384 -194 -473
Increase(-)/decrease(+) in net
debt
-125 -405 -181 -403
Key ratios
Working capital/sales, % 25
Capital expenditures/sales, % 4
Balance sheet items, SEK m 6/30 2023 12/31 2022
Net debt 3,735 3,330
6/30 2023 6/30 2022
Number of employees 1,830 1,755

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A provider of scientific and analytical instruments for the biotechnology, clinical and food & beverage industries. Read more at www.aicompanies.com

Activities during the quarter

  • Organic sales growth declined by 1 percent in constant currency and continued to be impacted by soft demand and a strong prior year comparison for instruments sold into the biopharmaceutical end market. Both consumables and services demonstrated strong organic growth, partially offsetting the weakness in instrument demand.
  • The underlying EBITA margin declined by 2 percentage points (adjusting for approximately USD 7m in Artel-related transaction expenses in the previous year). The lower margin is mainly explained by the weaker instrument sales, significant investments in the global commercial organization and R&D, and product mix impact following the Artel acquisition.

Key figures, Advanced Instruments

Income statement items, 2023 2022
USD m Q2 H1 Q2 H1 Last 12
months
Sales 37 71 33 65 141
EBITDA 16 28 8 21 52
EBITA 15 27 7 20 49
Sales growth, % 12 10 41 42
Organic growth,
constant currency, %
-1 -5 16 17
EBITDA, % 42.7 39.5 22.7 33.2 36.8
EBITA, % 40.7 37.5 21.3 31.7 35.0
Cash flow items, USD m Q2 H1 Q2 H1
EBITDA 16 28 8 21
Lease payments 0 0 0 0
Change in working capital 1 -4 1 -7
Capital expenditures -1 -1 -1 -1
Operating cash flow 16 23 8 13
Acquisitions/divestments -1 -32 -71 -71
Shareholder - - 50 50
contribution/distribution
Other1) -7 -14 -2 -5
Increase(-)/decrease(+) in net
debt
8 -23 -16 -13
Key ratios
Working capital/sales, % 9
Capital expenditures/sales, % 1
Balance sheet items, USD m 6/30 2023 12/31 2022
Net debt 229 206
6/30 2023 6/30 2022
Number of employees 325 350
1) Includes effects of exchange rate changes, interest, tax and change in lease

A provider of gripping and moving solutions for end-users and machine manufacturers to improve energy efficiency, productivity and work environment. Read more at www.piab.com

Activities during the quarter

  • Organic sales growth amounted to 4 percent in constant currency, driven by Vacuum Automation and Vacuum Conveying. On a regional level, growth was mainly driven by EMEA.
  • The EBITA margin was unchanged as underlying operating leverage was offset by investments in the commercial organization and in functional areas.
  • Integration of companies acquired in the last twelve months, including COVAL and IB Verfahrens- und Anlagentechnik, is progressing well.
  • Within Vacuum Automation, Piab has, in collaboration with Universal Robots, BINDER and Rocketfarm developed a collaborative robot cell for palletizing, the first solution of its kind improving flexibility, productivity, reliability and labor safety.

Key figures, Piab

Income statement items, 2023 2022 Last 12
SEK m Q2 H1 Q2 H1 months
Sales 789 1,509 619 1,169 2,790
EBITDA 222 428 173 334 712
EBITA 193 374 152 294 610
Sales growth, % 27 29 47 41
Organic growth,
constant currency, % 4 8 17 17
EBITDA, % 28.2 28.3 27.9 28.6 25.5
EBITA, % 24.5 24.8 24.5 25.2 21.9
Cash flow items, SEK m Q2 H1 Q2 H1
EBITDA 222 428 173 334
Lease payments -13 -24 -10 -19
Change in working capital 14 -45 -46 -130
Capital expenditures -24 -44 -15 -26
Operating cash flow 199 314 102 159
Acquisitions/divestments -12 -785 -499 -695
Shareholder
contribution/distribution
- 222 210 210
Other1) -332 -418 -250 -330
Increase(-)/decrease(+) in net
debt -145 -667 -437 -656
Key ratios
Working capital/sales, % 18
Capital expenditures/sales, % 3
Balance sheet items, SEK m 6/30 2023 12/31 2022
Net debt 3,097 2,431
6/30 2023 6/30 2022
Number of employees 1,185 995

1) Includes effects of exchange rate changes, interest, tax and change in lease liabilities.

A provider of mobility transportation solutions, including wheelchair accessible vehicles, lifts and seating, storage and securement products. Read more at www.braunability.com

Activities during the quarter

  • Organic sales growth amounted to 36 percent in constant currency, led by strong demand across the product portfolio.
  • The acquisitions of Q'Straint and the ProMaster wheelchairaccessible vehicle conversion business are performing well.
  • The EBITA margin improved, driven by operating leverage, cost efficiency improvements, and favorable product mix.

Key figures, BraunAbility

Income statement items, 2023 2022 Last 12
USD m Q2 H1 Q2 H1 months
Sales 288 538 211 435 1,032
EBITDA 37 70 17 39 117
EBITA 32 60 13 30 97
Sales growth, % 36 24 24 37
Organic growth,
constant currency, %
36 23 19 30
EBITDA, % 12.9 13.0 8.1 9.0 11.4
EBITA, % 11.1 11.1 5.9 6.8 9.4
Cash flow items, USD m Q2 H1 Q2 H1
EBITDA 37 70 17 39
Lease payments -2 -4 -2 -4
Change in working capital -6 -32 -10 -18
Capital expenditures -5 -9 -3 -5
Operating cash flow 24 24 3 12
Acquisitions/divestments - - - -8
Shareholder - - - -
contribution/distribution
Other1) -11 -18 -4 -7
Increase(-)/decrease(+) in net
debt
12 6 0 -2
Key ratios
Working capital/sales, % 7
Capital expenditures/sales, % 2
Balance sheet items, USD m 6/30 2023 12/31 2022
Net debt 277 284
6/30 2023 6/30 2022
Number of employees 2,035 1,890

Develops and manages properties within community service and commercial. Read more at www.vectura.se

Activities during the quarter

  • Total sales growth amounted to 9 percent, mainly driven by rent increases due to annual indexation.
  • The EBITDA margin decreased mainly driven by one-time costs.
  • Vectura signed a divestment of the majority of its Community Service portfolio to Altura (managed by NREP) for a total of nearly SEK 5bn. The annual return on investment has been approximately 15 percent during Vectura's ownership. The divestment is anchored in Vectura's new strategic direction, targeting growth within commercial properties, with the aim of creating innovation clusters such as Forskaren in Stockholm and GoCo Health Innovation City in Gothenburg.
  • Patricia Industries contributed SEK 400m in equity capital to fund the development of Saab's new R&D-focused office building in Lund.
  • Vectura has a strong pipeline of attractive opportunities. To support growth and strengthen Vectura's balance sheet, Patricia Industries is planning an additional capital contribution of approximately SEK 3.5bn during the third quarter 2023, with the majority to be repaid upon closing of the Community Service transaction in the first quarter 2024.

Key figures, Vectura

Income statement items, 2023 2022 Last 12
SEK m Q2 H1 Q2 H1 months
Sales 82 166 75 150 319
EBITDA 41 96 47 91 183
EBITDA, % 49.5 57.7 62.0 60.8 57.4
EBITA adj.1) 4 27 15 28 50
EBITA adj % 4.7 16.4 20.1 18.7 15.6
Balance sheet items, SEK m 6/30 2023 12/31 2022
Net debt 5,901 5,223
6/30 2023 12/31 2022
Real estate market value 10,276 9,650
6/30 2023 6/30 2022
Number of employees 50 41

1) EBITA adjusted for depreciation of surplus values related to properties.

A provider of advanced reagents for basic and clinical biomedical research. Read more at www.atlasantibodies.com

Activities during the quarter

  • Organic sales declined 6 percent in constant currency due to soft market demand.
  • The EBITA margin decreased, mainly driven by one-time costs.
  • Atlas Antibodies released a set of new monoclonal antibodies, complementing the portfolio for cancer research.

Key figures, Atlas Antibodies

Income statement items, 2023 2022 Last 12
SEK m Q2 H1 Q2 H1 months
Sales 108 219 104 200 417
EBITDA 43 97 48 93 191
EBITA 36 82 42 82 164
Sales growth, % 4 9 29 27
Organic growth,
constant currency, %
-6 1 21 21
EBITDA, % 40.0 44.3 45.7 46.5 45.8
EBITA, % 32.9 37.4 40.4 41.2 39.5
Cash flow items, SEK m Q2 H1 Q2 H1
EBITDA 43 97 48 93
Lease payments -4 -7 -2 -4
Change in working capital 4 -13 -22 -48
Capital expenditures -8 -13 -6 -9
Operating cash flow 36 64 18 32
Acquisitions/divestments - - - -
Shareholder
contribution/distribution
- - - -
Other1) -1 -60 -6 -17
Increase(-)/decrease(+) in net
debt 34 4 12 15
Key ratios
Working capital/sales, % 50
Capital expenditures/sales, % 5
Balance sheet items, SEK m 6/30 2023 12/31 2022
Net debt 338 342
6/30 2023 6/30 2022
Number of employees 120 120

Provides mobile voice and broadband services in Sweden and Denmark. Read more at www.tre.se.

Activities during the quarter

  • The subscription base increased by 59,000, of which 38,000 in Sweden and 21,000 in Denmark. Three Sweden reached a milestone with 2.5 million subscriptions.
  • Service revenue increased by 11 percent, driven by a larger customer base as well as price increases on both brands, 3Sweden and hallon. EBITDA increased by 8 percent.
  • Three Sweden launched eco-friendly subscriptions for its business customers, labelled as Good Environmental Choice by The Swedish Society for Nature Conservation. These subscriptions include, for example, discounts on mobile repair services and mobile trade-in program.
  • Three Sweden reached a shared first place for 5G coverage according to Open Signal's latest report "Mobile Network Experience Report June 2023" and also ranked as the winner in the categories "Excellent Consistent Quality" and "Overall Availability".

Key figures, Three Scandinavia

2023 2022 Last 12
Income statement items Q2 H1 Q2 H1 months
Sales, SEK m 3,004 6,025 2,798 5,526 12,333
Sweden, SEK m 1,908 3,819 1,817 3,566 7,921
Denmark, DKK m 708 1,452 700 1,394 2,963
Service revenue, SEK m1) 2,035 3,996 1,831 3,616 7,885
Sweden, SEK m 1,274 2,518 1,169 2,306 4,964
Denmark, DKK m 492 972 472 931 1,961
EBITDA, SEK m 989 1,858 917 1,807 3,779
Sweden, SEK m 716 1,381 675 1,331 2,782
Denmark, DKK m 177 312 172 339 668
EBITDA, % 32.9 30.8 32.8 32.7 30.6
Sweden 37.5 36.2 37.2 37.3 35.1
Denmark 24.9 21.5 24.6 24.3 22.6
Key ratios
Capital expenditures/sales, % 18
Balance sheet items, SEK m 6/30 2023 12/31 2022
Net debt 7,491 7,294
6/30 2023 6/30 2022
Number of employees 1,790 1,715
Other key figures 6/30 2023 6/30 2022
Subscriptions 4,098,000 3,901,000
Sweden 2,525,000 2,377,000
Denmark 1,573,000 1,524,000

1) Mobile service revenue excluding interconnect revenue.

Investments in EQT

EQT is a purpose-driven global investment organization focused on active ownership strategies. With a Nordic heritage and a global mindset, EQT has a track record of almost three decades of delivering consistent and attractive returns across multiple geographies, sectors and strategies. Investor was one of the founders of EQT in 1994 and has committed capital to the vast majority of its funds. Read more at www.eqtgroup.com

Highlights during the quarter

• The reported value change of Investments in EQT was 3 percent. Net cash flow to Investor amounted to SEK 536m.

Performance

Contribution to net asset value (adjusted and reported) amounted to SEK -272m during the first half of 2023 (-43,126), of which SEK 2,273m during the second quarter (-25,618).

The reported value change of Investor's investments in EQT was 0 percent during the first half of 2023, of which -3 percent in constant currency.

During the second quarter, the value change amounted to 3 percent, of which 1 percent in constant currency.

Net cash flow to Investor amounted to SEK -214m during the first half of 2023, of which SEK 536m during the second quarter.

Investments in EQT AB

Total shareholder return for the first half of 2023 amounted to -5 percent, of which -1 percent during the second quarter.

Dividends received amounted to SEK 261m during the first half of 2023, of which SEK 261m during the second quarter.

Investments in EQT funds

Investor reports the value change on its EQT fund investments with a one-quarter lag. Consequently, the information related to Investor's investments in EQT funds in this report is presented as of March 31, 2023.

During the first half of 2023, the reported value change of Investor's investments in EQT funds amounted to 6 percent, of which 0 percent in constant currency.

During the second quarter, the reported value change amounted to 8 percent, of which 4 percent in constant currency.

Investor's total outstanding commitments to EQT funds amounted to SEK 24.4bn as of June 30, 2023 (25.6).

Change in adjusted net asset value, EQT

SEK m Q2 2023 H1 2023 H1 2022
Net asset value, beginning of
period
68,254 70,050 116,640
Contribution to net asset value
Drawdowns (investments,
management fees and management
2,273 -272 -43,126
cost)
Proceeds to Investor (divestitures,
439 2,310 2,740
fee surplus, carry and dividend) -975 -2,096 -6,607
Net asset value, end of period 69,992 69,992 69,647

Investor

Investor's investments in EQT, June 30, 20231)

Fund
size
Outstanding
commitment
Reported
value
EUR m Share (%) SEK m SEK m
Fully invested funds2) 42,451 3,275 17,813
EQT IX 15,600 3 635 6,509
EQT Infrastructure V 15,700 3 1,603 4,428
Credit Opportunities III3) 1,272 10 588 551
EQT Growth 2,200 3 517 208
EQT Ventures II 619 3 12 267
EQT Ventures III 1,000 3 269 75
EQT Mid Market Asia III 630 27 228 1,799
EQT Mid Market Europe 1,616 9 246 1,846
EQT Real Estate II 1,000 3 181 230
EQT new funds - - 16,870 65
Total fund investments 82,088 24,425 33,793
EQT AB 14.7/14.74) 36,200
Total investments in EQT 69,992

1) Investor's investments in EQT funds are reported with a one-quarter lag.

2) EQT VI, EQT VII, EQT VIII, EQT Expansion Capital II, EQT Infrastructure I, II, III and IV, EQT Credit Fund II, EQT Mid Market, EQT Mid Market US, EQT Real Estate I, EQT Ventures.

3) Divested by EQT AB to Bridgepoint, October 2020.

4) Capital and votes respectively.

Investor's investments in EQT, key figures overview

SEK m Q2
2023
Q1
2023
FY
2022
Q4
2022
Q3
2022
Q2
2022
Q1
2022
FY
2021
Q4
2021
Q3
2021
Q2
2021
Reported value 69,992 68,254 70,050 70,050 70,260 69,647 99,078 116,640 116,640 90,889 78,467
Reported value
change, %
3 -4 -35 2 2 -26 -15 111 30 16 9
Value change,
constant currency, %
1 -4 -37 1 1 -27 -15 110 30 16 9
Drawdowns from
Investor
439 1,871 4,000 832 428 847 1,893 8,068 3,120 2,258 1,169
Proceeds to Investor 975 1,121 10,220 2,257 1,355 4,660 1,947 12,902 4,965 2,550 4,986
Net cash flow to
Investor
536 -749 6,220 1,426 927 3,813 54 4,834 1,845 292 3,817

Investor Group

Net debt

Net debt totaled SEK 13,218m on June 30, 2023 (10,263). Debt financing of the Patricia Industries' subsidiaries is arranged without guarantees from Investor and hence not included in Investor's net debt. Investor guarantees SEK 2.4bn of the associated company Three Scandinavia's refinanced external debt, but this guaranteed loan is not included in Investor's net debt. The same applies for pending dividends from investments and approved but not yet paid dividend to shareholders.

Net debt, June 30, 2023

SEK m Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
net debt
Other financial
investments 10,232 -123 10,109
Cash, bank and short
term investments
Receivables included
26,174 -8,793 17,382
in net debt 1,149 -209 941
Interest bearing debt -96,091 54,544 -41,547
Provision for pensions -807 705 -102
Total -59,342 46,124 -13,218

Investor's gross cash amounted to SEK 27,491m as of June 30, 2023 (28,533). The short-term investments are invested conservatively, taking into account the riskadjusted return profile. Investor's gross debt, excluding pension liabilities, amounted to SEK 40,606m as of June 30, 2023 (38,695).

The average maturity of Investor AB's debt portfolio was 11.3 years on June 30, 2023 (11.8), excluding the debt of the Patricia Industries subsidiaries.

Investor is rated AA- (Stable Outlook) by S&P Global and Aa3 (Stable Outlook) by Moody's.

Debt maturity profile, June 30, 2023

Net financial items, H1 2023

SEK m Group -
Net financial
items
Deductions
related to
Patricia
Industries
Investor's net
financial
items
Interest income 79 -37 41
Interest expenses
Results from revaluation of
loans, swaps and short
-1,637 1,251 -386
term investments -360 585 225
Foreign exchange result -1,916 85 -1,831
Other -180 182 2
Total -4,015 2,066 -1,950

Parent Company

Share capital

Investor's share capital amounted to SEK 4,795m on June 30, 2023 (4,795).

Share structure
Class of
share
Number of
shares
Number of
votes
% of
capital
% of
votes
A 1 vote 1,246,763,376 1,246,763,376 40.6 87.2
B 1/10 vote 1,821,936,744 182,193,674 59.4 12.8
Total 3,068,700,120 1,428,957,050 100.0 100.0

Investor's share capital consists of 3,068,700,120 shares with a quota of SEK 1.5625 per share.

On June 30, 2023, Investor owned a total of 6,174,413 of its own shares (5,654,344).

Results and investments

The Parent Company's result after financial items was SEK 80,653m (-78,215). The result is mainly related to Listed Companies which contributed to the result with dividends amounting to SEK 8,762m (7,866) and value changes of SEK 74,369m (-84,631).

During 2023, the Parent Company invested SEK 562m in financial assets (3,349), of which SEK 562m in Group companies (495) as new loans and capitalization of interest and purchases in Listed Companies of SEK 0m (501). The Parent Company divested SEK 990m in Listed Companies during the year (1,662). During the year, the Parent Company received repayments of shareholder contribution of 8,950m (8 650) and repayments of loans of 421m (0) from subsidiaries. By the end of the period, Shareholder's equity totaled SEK 498,072m (431,034).

Other

Annual General Meeting

On May 3, 2023, Investor AB's Annual General Meeting (AGM) approved the Board of Directors' proposal of a dividend to the shareholders of SEK 4.40 per share for fiscal year 2022 (4.00). SEK 3.30 was paid out on May 10, 2023, and SEK 1.10 per share will be paid out on November 9, 2023.

Offers to chairpersons

Investor continues to offer chairpersons in companies within Listed Companies to invest in call options in their respective companies with a duration of five to seven

years, as the chairperson has a particularly important role in driving successful board work.

During the second quarter 2023, new 5-year options, with a strike price of 110 percent of the share price, were sold to the chairperson in Atlas Copco for a total consideration of SEK 5m.

During the first quarter 2023, five-year call options with a strike price of 110 percent have been sold to the chairperson of Epiroc for a total SEK 2m.

Acquisitions (business combinations)

Piab's acquisition of IB

On April 20, 2023, Piab finalized the acquisition of IB Verfahrens- und Anlagentechnik GmbH & Co. KG. IB develops and builds customer-specific, turnkey systems for filling, emptying, metering, and conveying bulk materials. The consideration amounted to SEK 116m and was funded in cash. The acquisition of IB product portfolio completes the Piab additive manufacturing offering and enables Piab Group to offer full powder handling solutions, particularly in the Food, Pharma and Chemical industries. In the preliminary purchase price allocation, goodwill amounted to SEK 115m. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 9m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until June 30, 2023, IB contributed net sales of SEK 12m and profit/loss of SEK 0m to the Group's result. If the acquisition had occurred on January 1, 2023,

management estimates that consolidated net sales for the Group would have increased by SEK 20m and consolidated profit/loss for the period would have increased by SEK 2m.

Piab's acquisition of COVAL

On March 28, 2023, Piab finalized the acquisition of COVAL, a global player in vacuum automation components and systems. The consideration amounted to SEK 715m and was funded with SEK 222m in equity from Patricia Industries, in addition to cash from Piab and external debt. The acquisition strengthens Piab's product portfolio and geographic footprint. In the preliminary purchase price allocation, goodwill amounted to SEK 400m. The goodwill recognized is not expected to be deductible for income tax purposes. Transaction related costs amounted to SEK 23m and derive from external legal fees and due diligence expenses. These costs have been included in the line item Administrative, research and development and other operating cost in the Group's consolidated income statement. For the period from the acquisition date until June 30, 2023, COVAL contributed net sales of SEK 84m and profit/loss of SEK 13m to the Group's result. If the acquisition of COVAL had occurred on January 1, 2023, management estimates that consolidated net sales for the Group would have increased by SEK 67m and consolidated profit/loss for the period would have increased by SEK 7m. In connection with the closing of the acquisition of COVAL a loan amounting to SEK 96m was repaid.

Identifiable assets acquired and liabilities assumed

SEK m IB COVAL Total
Intangible assets 2 234 235
Property, plant and equipment 0 75 75
Inventories 14 40 53
Trade receivables 8 46 54
Other current receivables 3 7 10
Cash and cash equivalents 9 38 46
Long-term interest bearing liabilities -15 -96 -111
Other provisions -2 -4 -6
Other liabilities -17 -24 -41
Net identifiable assets and liabilities 1 315 316
Consolidated goodwill 115 400 515
Consideration 116 715 832
Less: acquired cash and cash equivalents -9 -38 -46
Paid additional purchased price related to acquisitions made in previous periods 340
Acquisitions of subsidiaries, net effect on cash flow 108 677 1,125

Pledged assets and contingent liabilities

Total pledged assets amount to SEK 31.0bn (29.8), of which SEK 28.3bn (27.5) refers to pledged assets in the subsidiaries BraunAbility, Laborie, Advanced Instruments and Sarnova, related to outstanding loans corresponding to SEK 2.6bn, SEK 4.5bn, SEK 2.1bn and SEK 5.6bn.

Total contingent liabilities amount to SEK 2.5bn and refers to warranties within the wholly-owned subsidiaries (1.6).

Related party transactions

In January 2023, Vectura and Saab entered into a share purchase agreement and a lease agreement for new premises. Vectura shall produce and finance a new construction project with premises adapted for Saab. Access to the premises is expected by the end of 2025. The lease agreement has an initial term of 20 years. The total net present value of the transactions amounts to approximately SEK 610m.

Risks and uncertainties

The main risks that the Group and the Parent Company are exposed to are primarily related to the value changes of the listed assets due to market price fluctuations. The current uncertain market environment creates unpredictable near-term fluctuations in the financial markets. The global market development also affects the businesses of Investor's unlisted holdings'. The global economy continues to be affected by geopolitical tensions, Russia's invasion of Ukraine, supply chain constraints as well as inflation and interest rates. Investor's portfolio companies operate in several different industries, and they all face different situations. Based on Investor's governance model, each individual board and management team decides on appropriate actions related to the company's risks.

All companies have taken measures related to Russia's invasion of Ukraine, such as following sanctions, protecting and supporting employees, and several have wound down their Russian activities. The direct exposure to Russia and Ukraine is very small for Investor and its subsidiaries, and the direct financial impact from the war is negligible. However, the indirect impact due to fluctuations in the financial markets, higher prices on raw materials, inflation and central bank policies, can be substantial, but it is not possible to quantify these effects for the coming year. In 2022, Investor's net sales to Russia and Ukraine (related to the subsidiaries within Patricia Industries) amounted to less than SEK 100 m, corresponding to 0.19 percent of net sales for the Group. The Group has no production plants or other assets in the countries concerned. During the first and second quarter of 2023, no impairment has been made related to Russia's invasion of Ukraine.

Investor's risk management, risks and uncertainties are described more in detail in the Annual Report, (Administration report and Note 3).

Accounting policies

For the Group, this Interim Report is prepared in accordance with IAS 34 Interim Financial Reporting and applicable regulations in the Swedish Annual Accounts Act, and for the Parent Company in accordance with Sweden's Annual Accounts Act, chapter 9 Interim report. The accounting policies that have been applied for the Group and Parent Company, are in agreement with the accounting policies used in preparation of the company's most recent annual report.

Alternative Performance Measures

Investor applies the ESMA Guidelines on Alternative Performance Measures (APMs). An APM is a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework. For Investor's consolidated accounts, this framework typically means IFRS.

Definitions of all APMs used are found in the Annual Report 2022 and on www.investorab.com/investorsmedia/investor-in-figures/definitions.

Reconciliations to the financial statements for the APMs that are not directly identifiable from the financial statements and considered significant to specify, are disclosed on pages 31-32. Reconciliations of APMs for individual subsidiaries or business areas are not disclosed, since the purpose of these are to give deeper financial information without being directly linked to the financial

information for the Group, that is presented according to the applicable financial reporting framework.

Roundings

Due to rounding, numbers presented throughout this Interim Report may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Financial calendar

Oct. 19, 2023 Interim Management Statement
January-September 2023
Jan. 19, 2024 Year-End Report 2023
Apr. 18, 2024 Interim Management Statement
January-March 2024
Jul. 17, 2024 Interim Report

January-June 2024

For more information

Helena Saxon Chief Financial Officer +46 8 614 2000 [email protected]

Viveka Hirdman-Ryrberg Head of Corporate Communication and Sustainability +46 70 550 3500 [email protected]

Magnus Dalhammar Head of Investor Relations +46 73 524 2130 [email protected]

Address

Investor AB (publ) (CIN 556013-8298) SE-103 32 Stockholm, Sweden Visiting address: Arsenalsgatan 8C Phone: +46 8 614 2000 www.investorab.com

Ticker codes

INVEB SS in Bloomberg INVEb.ST in Reuters INVE B in NASDAQ OMX

Information about Investor is also available on LinkedIn.

This information is information that Investor AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, at 12:00 CET on July 17, 2023.

This Interim Report and additional information is available on www.investorab.com

The Board of Directors declares that the six-month Interim Report provides a true and fair overview of the Parent Company's and Group's operations, their financial position and performance, and describes material risks and uncertainties facing the Parent Company and other companies in the Group.

Stockholm, July 17, 2023

Jacob Wallenberg Chairman

Tom Johnstone, CBE Grace Reksten Skaugen Marcus Wallenberg

Hans Stråberg Isabelle Kocher Sven Nyman

Gunnar Brock Sara Öhrvall Magdalena Gerger Director Director Director

Director Director Vice Chairman

Director Director Director

Johan Forssell President and Chief Executive Officer Director

Review Report

Introduction

We have reviewed the Interim report of Investor AB (publ), corporate identity number 556013-8298, for the period January 1-June 30, 2023. The Board of Directors and the President are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.

Scope of Review

We conducted our review in accordance with the International Standard on Review Engagements ISRE 2410, Review of Interim Financial Information Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review has a different focus and is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (ISA) and other generally accepted auditing practices. The procedures performed in a review do not enable us to obtain a level of assurance that would

make us aware of all significant matters that might be identified in an audit.

Therefore, the conclusion expressed based on a review does not give the same level of assurance as a conclusion expressed based on an audit.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the Interim report is not, in all material respects, prepared for the Group in accordance with IAS 34 and the Annual Accounts Act, and for the Parent Company in accordance with the Annual Accounts Act.

Stockholm, July 17, 2023

Deloitte AB

For signature, please see Swedish version

Jonas Ståhlberg

Authorized Public Accountant

Consolidated Income Statement, in summary

SEK m H1 2023 H1 2022 Q2 2023 Q2 2022
Dividends 9,432 8,453 5,218 1,782
Changes in value 69,670 -141,384 41,309 -65,808
Net sales 28,841 23,929 14,831 12,280
Cost of goods and services sold -15,323 -13,113 -7,859 -6,711
Sales and marketing cost -4,274 -3,615 -2,180 -1,830
Administrative, research and development and other
operating cost
-5,320 -4,794 -2,717 -2,500
Management cost -316 -285 -162 -152
Share of results of associates 72 8 45 -18
Operating profit/loss 82,781 -130,800 48,486 -62,957
Net financial items -4,015 -3,493 -2,832 -2,366
Profit/loss before tax 78,766 -134,294 45,654 -65,323
Income taxes -645 -352 -346 -198
Profit/loss for the period 78,121 -134,646 45,309 -65,521
Attributable to:
Owners of the Parent Company 78,191 -134,582 45,343 -65,490
Non-controlling interest -70 -64 -35 -31
Profit/loss for the period 78,121 -134,646 45,309 -65,521
Basic earnings per share, SEK 25.53 -43.93 14.80 -21.38
Diluted earnings per share, SEK 25.51 -43.93 14.80 -21.38

Consolidated Statement of Comprehensive Income, in summary

SEK m H1 2023 H1 2022 Q2 2023 Q2 2022
Profit/loss for the period 78,121 -134,646 45,309 -65,521
Other comprehensive income for the period, including tax
Re-measurements of defined benefit plans 15 65 15 65
Items that may be recycled to profit/loss for the period
Cash flow hedges 5 51 7 16
Hedging costs 15 77 10 60
Foreign currency translation adjustment 4,528 6,297 4,136 5,002
Share of other comprehensive income of associates 79 60 83 39
Total other comprehensive income for the period 4,641 6,550 4,251 5,182
Total comprehensive income for the period 82,762 -128,096 49,560 -60,338
Attributable to:
Owners of the Parent Company 82,823 -128,066 49,572 -60,336
Non-controlling interest -60 -30 -12 -3
Total comprehensive income for the period 82,762 -128,096 49,560 -60,338
SEK m 6/30 2023 12/31 2022 6/30 2022
ASSETS
Goodwill 66,801 63,334 61,828
Other intangible assets 34,293 34,355 35,315
Property, plant and equipment 12,940 16,239 14,898
Shares and participations 621,530 550,556 493,460
Other financial investments 10,232 9,705 11,585
Long-term receivables included in net debt 1,149 945 1,230
Other long-term receivables 3,272 2,873 3,022
Total non-current assets 750,218 678,006 621,338
Inventories 10,682 9,583 8,836
Shares and participations in trading operation 1,049 873 205
Short-term receivables included in net debt - - 2
Other current receivables 10,592 9,598 10,789
Cash, bank and short-term investments 26,174 26,304 27,955
Assets held for sale 4,434 - -
Total current assets 52,932 46,358 47,786
TOTAL ASSETS 803,150 724,365 669,124
EQUITY AND LIABILITIES
Equity 674,817 605,653 542,760
Long-term interest bearing liabilities 84,204 89,436 87,728
Provisions for pensions and similar obligations 807 799 1,022
Other long-term provisions and liabilities 15,559 14,973 15,477
Total non-current liabilities 100,569 105,209 104,227
Current interest bearing liabilities 11,887 1,783 8,984
Other short-term provisions and liabilities 15,656 11,719 13,153
Liabilities directly associated with assets held for sale 221 - -
Total current liabilities 27,764 13,502 22,137
TOTAL EQUITY AND LIABILITIES 803,150 724,365 669,124

Consolidated Statement of Changes in Equity, in summary

SEK m H1 2023 2022 H1 2022
Opening balance 1/1 605,653 683,505 683,505
Profit for the period 78,121 -74,762 -134,646
Other comprehensive income for the period 4,641 9,550 6,550
Total comprehensive income for the period 82,762 -65,212 -128,096
Dividend to shareholders -13,477 -12,254 -12,254
Changes in non-controlling interest 21 -282 -260
Effect of long-term share-based remuneration 56 42 11
Purchase of own shares -199 -147 -147
Closing balance 674,817 605,653 542,760
Attributable to:
Owners of the Parent Company 674,068 604,865 541,955
Non-controlling interest 749 788 805
Total equity 674,817 605,653 542,760
Consolidated Cash Flow, in summary
SEK m H1 2023 H1 2022
Operating activities
Dividends received 9,432 8,533
Cash receipts 27,472 21,584
Cash payments -22,999 -19,158
Cash flows from operating activities before net interest and income tax 13,905 10,959
Interest received/paid -1,313 -1,284
Income tax paid -691 -681
Cash flows from operating activities 11,900 8,994
Investing activities
Acquisitions1) -2,742 -2,762
Divestments2) 3,311 8,109
Increase in long-term receivables -106 -19
Decrease in long-term receivables -1 19
Acquisitions of subsidiaries, net effect on cash flow -1,158 -2,137
Divestments of subsidiaries, net effect on cash flow - 67
Increase in other financial investments3) -7,670 -439
Decrease in other financial investments4) 7,340 3,142
Net change, short-term investments5) 3,796 -4,715
Acquisitions of property, plant and equipment -1,571 -2,627
Proceeds from sale of property, plant and equipment 15 328
Net cash used in investing activities 1,214 -1,035
Financing activities
New share issue - 21
Borrowings 2,616 11,726
Repayment of borrowings -2,256 -6,097
Repurchases of own shares -204 -147
Dividend paid -10,130 -9,191
Net cash used in financing activities -9,974 -3,687
Cash flows for the period 3,140 4,272
Cash and cash equivalents at the beginning of the year 13,164 18,330
Exchange difference in cash 440 489
Cash and cash equivalents at the end of the period 16,745 23,091

1) Acquisitions include investments in listed and unlisted companies not defined as subsidiaries.

2) Divestments include sale of listed and unlisted companies not defined as subsidiaries.

3) Increase in other financial investments include acquisition of bond with maturity later than 1 year.

4) Decrease in other financial investments include disposals of reclassification of bonds with maturity later than 1 year.

5) Net changes, short-term investments includes acquisitions and disposals of bonds and certificates with maturity within 1 year.

Performance by Business Area Q2 2023

Listed Patricia Investments in Investor
SEK m Companies Industries EQT Groupwide Total
Dividends 4,953 - 261 3 5,218
Changes in value 40,736 -18 607 -16 41,309
Net sales - 14,831 - - 14,831
Cost of goods and services sold - -7,859 - - -7,859
Sales and marketing cost - -2,180 - - -2,180
Administrative, research and development and other operating cost - -2,713 -1 -3 -2,717
Management cost -40 -80 -3 -39 -162
Share of results of associates - 45 - - 45
Operating profit/loss 45,649 2,027 864 -54 48,486
Net financial items - -1,382 - -1,449 -2,832
Income tax - -232 - -113 -346
Profit/loss for the period 45,649 412 864 -1,617 45,309
Non-controlling interest - 35 - 0 35
Net profit/loss for the period attributable to the Parent Company 45,649 447 864 -1,617 45,343
Dividend to shareholders - - - -13,477 -13,477
Other effects on equity - 2,711 1,409 -60 4,060
Contribution to net asset value 45,649 3,158 2,273 -15,155 35,926
Net asset value by business area 6/30 2023
Carrying amount 546,431 74,482 69,992 -3,620 687,285
Investors net debt/-cash - 11,530 - -24,748 -13,218
Total net asset value including net debt/-cash 546,431 86,013 69,992 -28,368 674,068

Performance by Business Area Q2 2022

Listed Patricia Investments in Investor
SEK m Companies Industries EQT Groupwide Total
Dividends 1,537 - 244 1 1,782
Changes in value -38,322 -605 -26,880 0 -65,808
Net sales - 12,280 - - 12,280
Cost of goods and services sold - -6,711 - 0 -6,711
Sales and marketing cost - -1,830 - - -1,830
Administrative, research and development and other operating cost - -2,493 -1 -6 -2,500
Management cost -37 -78 -3 -34 -152
Share of results of associates - -18 - - -18
Operating profit/loss -36,822 545 -26,640 -39 -62,957
Net financial items - -1,062 - -1,304 -2,366
Income tax - -142 - -56 -198
Profit/loss for the period -36,822 -659 -26,640 -1,400 -65,521
Non-controlling interest - 31 - 0 31
Net profit/loss for the period attributable to the Parent Company -36,822 -628 -26,640 -1,400 -65,490
Dividend to shareholders - - - -12,254 -12,254
Other effects on equity - 3,797 1,022 9 4,828
Contribution to net asset value -36,822 3,169 -25,618 -13,645 -72,916
Net asset value by business area 6/30 2022
Carrying amount 417,215 72,822 69,647 -3,265 556,419
Investors net debt/-cash - 7,340 - -21,804 -14,464
Total net asset value including net debt/-cash 417,215 80,162 69,647 -25,069 541,955

Performance by Business Area H1 2023

Listed Patricia Investments in Investor
SEK m Companies Industries EQT Groupwide Total
Dividends 9,165 - 261 6 9,432
Changes in value 72,123 -108 -2,338 -6 69,670
Net sales - 28,841 - - 28,841
Cost of goods and services sold - -15,323 - - -15,323
Sales and marketing cost - -4,274 - - -4,274
Administrative, research and development and other operating cost - -5,305 -3 -13 -5,320
Management cost -79 -157 -5 -74 -316
Share of results of associates - 72 - - 72
Operating profit/loss 81,209 3,745 -2,085 -87 82,781
Net financial items - -2,066 - -1,950 -4,015
Income tax - -518 - -127 -645
Profit/loss for the period 81,209 1,161 -2,085 -2,164 78,121
Non-controlling interest - 70 - 0 70
Net profit/loss for the period attributable to the Parent Company 81,209 1,231 -2,085 -2,164 78,191
Dividend to shareholders - - - -13,477 -13,477
Other effects on equity - 2,699 1,813 -23 4,489
Contribution to net asset value 81,209 3,930 -272 -15,664 69,203
Net asset value by business area 6/30 2023
Carrying amount 546,431 74,482 69,992 -3,620 687,285
Investors net debt/-cash - 11,530 - -24,748 -13,218
Total net asset value including net debt/-cash 546,431 86,013 69,992 -28,368 674,068

Performance by Business Area H1 2022

Listed Patricia Investments in Investor
SEK m Companies Industries EQT Groupwide Total
Dividends 8,207 - 244 2 8,453
Changes in value -96,214 -434 -44,698 -38 -141,384
Net sales - 23,929 - - 23,929
Cost of goods and services sold - -13,113 - 0 -13,113
Sales and marketing cost - -3,615 - - -3,615
Administrative, research and development and other operating cost - -4,777 -2 -15 -4,794
Management cost -69 -149 -5 -62 -285
Share of results of associates - 8 - - 8
Operating profit/loss -88,076 1,850 -44,461 -113 -130,800
Net financial items - -1,397 - -2,096 -3,493
Income tax - -340 - -13 -352
Profit/loss for the period -88,076 113 -44,461 -2,222 -134,646
Non-controlling interest - 64 - 0 64
Net profit/loss for the period attributable to the Parent Company -88,076 177 -44,461 -2,222 -134,582
Dividend to shareholders - - - -12,254 -12,254
Other effects on equity - 4,807 1,335 35 6,178
Contribution to net asset value -88,076 4,984 -43,126 -14,441 -140,659
Net asset value by business area 6/30 2022
Carrying amount 417,215 72,822 69,647 -3,265 556,419
Investors net debt/-cash - 7,340 - -21,804 -14,464
Total net asset value including net debt/-cash 417,215 80,162 69,647 -25,069 541,955
Parent Company Income Statement, in summary
SEK m H1 2023 H1 2022 Q2 2023 Q2 2022
Dividends 8,762 7,866 4,822 1,428
Changes in value 74,367 -84,645 39,709 -35,786
Net sales 6 8 3 4
Operating cost -250 -221 -128 -119
Operating profit/loss 82,885 -76,992 44,405 -34,473
Profit/loss from financial items
Net financial items -2,232 -1,223 -1,586 -783
Profit/loss after financial items 80,653 -78,215 42,820 -35,257
Income tax - - - -
Profit/loss for the period 80,653 -78,215 42,820 -35,257

Parent Company Balance Sheet, in summary SEK m 6/30 2023 12/31 2022 6/30 2022 ASSETS Intangible assets and Property, plant and equipment 19 18 18 Financial assets 552,134 487,756 446,019 Total non-current assets 552,153 487,774 446,037 Current receivables 1,058 489 299 Cash and cash equivalents - - - Total current assets 1,058 489 299 TOTAL ASSETS 553,211 488,263 446,336 EQUITY AND LIABILITIES Equity 498,072 431,034 381,175 Provisions 140 128 106 Non-current liabilities, interest bearing 48,160 45,940 44,654 Total non-current liabilities 48,301 46,068 44,760 Current liabilities, interest bearing 0 0 7,474 Current liabilities 6,838 11,160 12,926 Total current liabilities 6,838 11,160 20,401 TOTAL EQUITY AND LIABILITIES 553,211 488,263 446,336

Financial instruments

The numbers below are based on the same accounting and valuation policies as used in the preparation of the company's most recent annual report. For information regarding financial instruments in level 2 and level 3, see Note 31, Financial Instruments, in Investor's Annual Report 2022.

Valuation techniques, level 3

Fair value, SEK m Range
Group 6/30 2023 12/31 2022 Valuation technique Input 6/30 2023 12/31 2022
Shares and participations 36,097 34,184 Last round of financing n/a n/a n/a
Comparable companies EBITDA multiples n/a n/a
Comparable companies Sales multiples 1.3 – 3.4 0.9 – 3.3
Comparable transactions Sales multiples 1.7 – 3.0 1.2 – 2.5
NAV n/a n/a n/a
Other financial investments 26 25 Discounted cash flow Market interest rate n/a n/a
Long-term and current receivables 2,957 2,543 Discounted cash flow Market interest rate n/a n/a
Long-term interest bearing liabilities 16 17 Discounted cash flow Market interest rate n/a n/a

Other provisions and liabilities 7,358 6,735 Comparable companies EBITDA multiples n/a n/a All valuations in level 3 are based on assumptions and judgments that management considers to be reasonable based on the circumstances prevailing at the time. Changes in assumptions may result in adjustments to reported values and the actual outcome may differ from the estimates and judgments that were made. Shares and participations in level 3 are mainly fund investments within EQT. Unlisted holdings in funds are measured at Investor's share of the value that the fund manager reports for all unlisted fund holdings (Net Asset Value) and is normally updated when a new valuation is received. The value change on Investor's investments in EQT funds are reported with a one-quarter lag. Part of the unlisted portfolio is valued based on comparable companies, and the value is dependent on the level of the multiples. The multiple ranges provided in the note show the minimum and maximum value of the actual multiples applied in these valuations. A 10 percent change of the multiples would have an effect on this part of the unlisted portfolio of approximately SEK 160m (200). For the derivatives, a parallel shift of the interest rate curve by one percentage point would affect the value by approximately SEK 640m (660).

Financial assets and liabilities by level

The table below indicates how fair value is measured for the financial instruments recognized at fair value in the Balance Sheet. The financial instruments are presented in three categories, depending on how the fair value is measured: Level 1: According to quoted prices in active markets for identical instruments

Level 2: According to directly or indirectly observable inputs that are not included in level 1

Level 3: According to inputs that are unobservable in the market

Financial instruments - fair value

6/30 2023 12/31 2022
Group Total
carrying
Total
carrying
SEK m Level 1 Level 2 Level 3 Other1) amount Level 1 Level 2 Level 3 Other1) amount
Financial assets
Shares and participations 579,976 2,713 36,097 2,743 621,530 511,703 2,167 34,184 2,502 550,556
Other financial investments 10,110 - 26 96 10,232 9,591 - 25 89 9,705
Long-term receivables included in
net debt
- 92 1,058 - 1,149 - - 945 - 945
Other long-term receivables - - 1,900 1,373 3,272 - - 1,598 1,275 2,873
Shares and participations in
trading operation
1,049 - - - 1,049 873 - - - 873
Other current receivables - 18 - 10,574 10,592 0 41 - 9,557 9,598
Cash, bank and short-term
investments
17,174 - - 9,001 26,174 18,767 - - 7,537 26,304
Total 608,309 2,823 39,081 23,787 674,000 540,935 2,208 36,752 20,960 600,855
Financial liabilities
Long-term interest bearing
liabilities
- - 16 84,188 84,2042) - - 17 89,420 89,4362)
Other long-term provisions and
liabilities
- - 7,316 8,243 15,559 - - 6,692 8,282 14,973
Short-term interest bearing
liabilities
- - - 11,887 11,8873) - 48 - 1,735 1,7833)
Other short-term provisions and
liabilities
159 94 42 15,361 15,656 179 77 44 11,419 11,719
Total 159 94 7,374 119,679 127,306 179 125 6,752 110,856 117,912

1) To enable reconciliation with balance sheet items, financial instruments not valued at fair value as well as other assets and liabilities that are included within balance sheet items

have been included within Other. 2) The Group's loans are valued at amortized cost. Fair value on long-term loans amounts to SEK 76,551m (80,997).

3) The Group's loans are valued at amortized cost. Fair value on short-term loans amounts to SEK 11,792m (1,783).

Changes in financial assets and liabilities in Level 3

Group 6/30 2023

Shares and Other
financial
Long-term
receivables
included in
Long-term
interest
bearing
Other long
term
provisions and
Other
current
SEK m participations investments net debt liabilities liabilities liabilities
Opening balance at the beginning of the year 34,184 25 2,543 17 6,692 44
Total gain or losses in profit or loss statement
in line Changes in value 6 - 294 - -35 -
in line Net financial items - - 143 0 588 -2
Reported in other comprehensive income
in line Cash flow hedges - - -35
in line Foreign currency translation adjustment 1,976 1 5 - 217 0
Acquisitions 2,213 - 12 - - -
Divestments -2,237 - - - -141 -
Issues - - - - 4 -
Settlements - - -5 - -9 -
Transfer out of Level 3 -44 - - - - -
Carrying amount at end of the period 36,097 26 2,957 16 7,316 42
Total unrealized gains/losses for the period included in profit/loss for financial
instruments held at the end of the period
Changes in value 3,750 - 294 - -3 -
Net financial items - - 143 0 -536 -
Total 3,750 - 437 0 -540 -

Changes in financial assets and liabilities in Level 3

Group 12/31 2022

SEK m Shares and
participations
Other
financial
investments
Long-term
receivables
included in
net debt
Long-term
interest
bearing
liabilities
Other long
term
provisions and
liabilities
Other
current
liabilities
Opening balance at the beginning of the year 33,756 160 3,745 46 5,935 101
Total gain or losses in profit or loss statement
in line Changes in value 3,789 -26 -139 - -1 -
in line Net financial items - -4 -1,168 -29 209 -55
in line Cost of goods and services sold 0 - - - -4 -
Reported in other comprehensive income
in line Cash flow hedges 144
in line Foreign currency translation adjustment 3,308 18 44 - 562 1
Acquisitions 3,671 - - - - -
Divestments -10,341 -116 - - - -
Issues - - 11 - - -
Settlements - - -95 - -9 -3
Transfer out of Level 3 - -6 - - - -
Carrying amount at end of the period 34,184 25 2,543 17 6,692 44
Total unrealized gains/losses for the period included in profit/loss for financial
instruments held at the end of the period
Changes in value -2,435 - - - -65 -
Net financial items - - -1,168 29 - -
Total -2,435 - -1,168 29 -65 -

Revenue from contracts with customers

As a consequence of a review of Investor's field of operations within Patricia Industries, a new field of operation has been created, Life Science. The new field of operation includes the former fields Health care services and Osmolality testing. Comparative figures have been reclassified to conform to the presentation of the current year's figures.

Group H1 2023 Field of operations
SEK m Healthcare
equipment
Life science Real estate Gripping and
moving
solutions
Total
Geographical market
Sweden 480 77 157 57 771
Scandinavia, excl. Sweden 755 11 - 34 800
Europe, excl. Scandinavia 6,377 247 - 611 7,235
U.S. 16,152 607 - 427 17,186
North America, excl. U.S. 485 35 - 86 606
South America 209 5 - 54 268
Africa 204 3 - 5 212
Australia 531 10 - 5 546
Asia, excl. China 569 36 - 70 674
China 361 22 - 160 544
Total 26,123 1,053 157 1,509 28,841
Category
Sales of products 25,056 709 - 1,481 27,246
Sales of services 1,031 344 - 28 1,403
Revenues from leasing 32 - 156 - 188
Other income 3 0 1 - 4
Total 26,123 1,053 157 1,509 28,841
Sales channels
Through distributors 14,849 381 - 832 16,062
Directly to customers 11,275 671 157 677 12,780
Total 26,123 1,053 157 1,509 28,841
Timing of revenue recognition
Goods and services transferred
at a point of time 25,851 964 - 1,509 28,324
Goods and services transferred
over time 273 88 157 - 518
Total 26,123 1,053 157 1,509 28,841

Group H1 2022 Field of operations

Healthcare Gripping and
moving
SEK m equipment Life science Real estate solutions Total
Geographical market
Sweden 425 89 141 54 710
Scandinavia, excl. Sweden 675 9 - 23 707
Europe, excl. Scandinavia 5,363 174 - 454 5,990
U.S. 13,045 687 - 308 14,040
North America, excl. U.S. 458 27 - 61 545
South America 155 5 - 40 201
Africa 149 4 - 5 158
Australia 498 8 - 6 512
Asia 780 68 - 219 1,067
Total 21,548 1,070 141 1,169 23,929
Category
Sales of products 20,654 517 - 1,155 22,326
Sales of services 858 553 - 14 1,425
Revenues from leasing 32 - 141 - 172
Other income 5 - 0 - 5
Total 21,548 1,070 141 1,169 23,929
Sales channels
Through distributors 12,208 308 - 383 12,899
Directly to customers 9,340 762 141 786 11,030
Total 21,548 1,070 141 1,169 23,929
Timing of revenue recognition
Goods and services transferred
at a point of time 21,318 850 - 1,169 23,337
Goods and services transferred
over time 230 221 141 - 592
Total 21,548 1,070 141 1,169 23,929

Reconciliations of significant Alternative Performance Measures

In the financial statements issued by Investor, Alternative Performance Measures (APMs) are disclosed, which complete measures that are defined or specified in the applicable financial reporting framework, such as revenue, profit or loss or earnings per share.

APMs are disclosed when they complement performance measures defined by IFRS. The basis for disclosed APMs are that they are used by management to evaluate the financial performance and in so believed to give analysts and other stakeholders valuable information.

Investor AB discloses the definitions of all APMs used on http://www.investorab.com/investors-media/investor-infigures/definitions and on pages 153-154 in the Annual Report 2022. Below reconciliations of significant APMs to the most directly reconcilable line item, subtotal or total presented in the financial statements of the corresponding period are disclosed.

Gross cash

Gross cash or Investor's cash and readily available placements are defined as the sum of cash and cash equivalents, short-term investments and interest-bearing current and long-term receivables. Deductions are made for items related to subsidiaries within Patricia Industries.

Group 6/30 2023,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross cash
Group 12/31 2022,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross cash
Other financial Other financial
investments 10,232 -123 10,109 investments 9,705 -116 9,590
Cash, bank and short Cash, bank and short
term investments 26,174 -8,793 17,382 term investments 26,304 -7,361 18,943
Gross cash 36,407 -8,916 27,491 Gross cash 36,009 -7,476 28,533

Gross debt

Gross debt is defined as interest-bearing current and long-term liabilities, including pension liabilities, less derivatives with positive value related to the loans. Deductions are made for items related to subsidiaries within Patricia Industries.

Group 6/30 2023,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross debt
Group 12/31 2022,
SEK m
Consolidated
balance sheet
Deductions
related to
Patricia
Industries
Investor's
gross debt
Receivables included
in net debt
1,149 -209 941 Receivables included
in net debt
945 -148 797
Loans -96,091 54,544 -41,547 Loans -91,220 51,728 -39,492
Provision for pensions -807 705 -102 Provision for pensions -799 699 -101
Gross debt -95,749 55,040 -40,708 Gross debt -91,074 52,278 -38,796

Net debt

Gross debt less gross cash at Balance Sheet date.

Group 6/30 2023,
SEK m
Group 12/31 2022,
SEK m
Investor's gross cash -27,491 Investor's gross cash -28,533
Investor's gross debt 40,708 Investor's gross debt 38,796
Investor's net debt 13,218 Investor's net debt 10,263

Total assets

The net of all assets and liabilities not included in net debt. Total reported assets are based on reported values according to IFRS. Total adjusted assets are adjusted for estimated market values for Patricia Industries' major subsidiaries and partner-owned investments.

Group 6/30 2023,
SEK m
Consolidated
balance sheet
Deductions
related to non
controlling
interest
Investor's
net asset
value
Group 12/31 2022,
SEK m
Consolidated
balance sheet
Deductions
related to non
controlling
interest
Investor's
net asset
value
Equity
Investor's net debt
674,817 -749 674,068
13,218
Equity
Investor's net debt
605,653 -788 604,865
10,263
Total reported
assets
687,285 Total reported
assets
615,128
Adjustment for
estimated market
value Patricia
Industries holdings
98,992 Adjustment for
estimated market
value Patricia
Industries holdings
68,385
Total adjusted
assets
786,278 Total adjusted
assets
683,513

Net debt ratio (leverage)

Net debt ratio or leverage is defined as Net debt/Net cash as a percentage of total adjusted assets. The target leverange range is 0-10 percent (net debt to total adjusted assets) over a business cycle.

Group 6/30 2023, SEK m Net debt ratio Group 12/31 2022, SEK m Net debt ratio
Investor's net debt 13,218 = Investor's net debt 10,263 =
Total adjusted assets 786,278 1.7% Total adjusted assets 683,513 1.5%

Reported net asset value

Reported net asset value is equal to Investor's net asset value and equity attributable to owners of the Parent Company.

Adjusted net asset value

Net asset value based on estimated market values for Patricia Industries' major subsidiaries and partner-owned investments. The estimated market values are mainly based on valuation multiples, typically Enterprise value (EV)/Last 12 months' operating profit, for relevant listed peers and indices. More information about the assessment basis can be found in section Patricia Industries - valuation overview on page 8 and Patricia Industries, overview of estimated market values on page 35. In the table below there are a reconciliation between Reported net asset value and Adjusted net asset value. More details regarding the differences can be found in the table Net asset value overview on page 4.

Group 6/30 2023,
SEK m
Group 12/31 2022,
SEK m
Reported net asset value 674,068 Reported net asset value 604,865
Reported value for net assets Patricia
Industries
-74,482 Reported value for net assets Patricia
Industries
-70,110
Estimated market value Patricia
Industries holdings
173,475 Estimated market value Patricia
Industries holdings
138,495
Adjusted net asset value 773,060 Adjusted net asset value 673,250

Reported net asset value, SEK per share

Equity attributable to shareholders of the Parent Company in relation to the number of shares outstanding at the Balance Sheet date.

Group 6/30 2023, SEK m Net asset value,
SEK per share
Group 12/31 2022, SEK m Net asset value,
SEK per share
Investor's reported net asset value 674,068 Investor's reported net asset value 604,865
Number of shares, excluding own
shares
=
3,062,525,707
220 Number of shares, excluding own
shares
=
3,063,045,776
197

Adjusted net asset value, SEK per share

Total assets, including estimated market values for Patricia Industries' major subsidiaries and partner-owned investments, less net debt in relation to the number of shares outstanding at the Balance Sheet date.

Group 6/30 2023, SEK m Net asset value,
SEK per share
Group 12/31 2022, SEK m Net asset value,
SEK per share
Investor's adjusted net asset value 773,060 Investor's adjusted net asset value 673,250
Number of shares, excluding own
shares
=
3,062,525,707
252 Number of shares, excluding own
shares
=
3,063,045,776
220

Patricia Industries, key figures overview1)

Q2 Q1 FY Q4 Q3 Q2 Q1 FY Q4 Q3 Q2
2023 2023 2022 2022 2022 2022 2022 2021 2021 2021 2021
Mölnlycke (EUR m)
Sales
475 479 1,828 474 469 459 426 1,686 420 405 417
Sales growth, % 4 13 8 13 16 10 -4 -6 -24 -15 16
Organic growth, 6 13 4 9 9 5 -7 -6 -26 -16 18
constant currency, %
EBITDA 135 136 476 105 134 125 112 485 106 112 123
EBITDA, %
EBITA2)
28.4
119
28.3
120
26.1
410
22.2
89
28.6
118
27.2
108
26.4
96
28.8
421
25.1
89
27.5
95
29.4
107
EBITA, % 25.0 25.0 22.4 18.7 25.1 23.6 22.6 25.0 21.2 23.4 25.6
Operating cash flow 112 54 298 78 119 73 28 382 128 91 84
Net debt 1,492 1,584 1,621 1,621 1,418 1,478 1,522 1,510 1,510 1,568 1,623
Employees 8,705 8,870 8,775 8,775 8,800 8,625 8,340 8,315 8,315 8,175 8,040
Laborie (USD m)
Sales 89 84 339 89 85 87 79 313 84 74 80
Sales growth, % 2 7 8 6 15 9 4 36 20 19 85
Organic growth,
constant currency, %
2 8 12 9 20 9 4 21 14 6 67
EBITDA 29 25 97 29 26 23 18 93 22 20 28
EBITDA, % 32.8 29.3 28.6 32.7 31.3 26.8 23.1 29.9 26.4 27.7 34.5
EBITA2) 28 23 90 27 25 22 17 83 20 18 25
EBITA, % 31.1 27.5 26.7 30.6 29.5 25.0 21.0 26.6 24.2 24.4 31.3
Operating cash flow 12 23 49 14 20 13 2 60 20 16 22
Net debt 439 444 454 454 461 475 455 424 424 366 396
Employees 905 890 895 895 910 885 805 780 780 780 775
Sarnova (USD m)
Sales
Sales growth, %
247
17
244
10
917
10
245
6
239
4
211
15
222
16
835
15
233
17
230
34
183
10
Organic growth,
constant currency, % 17 10 2 6 -5 6 3 0 0 14 -3
EBITDA 40 34 135 41 36 28 30 104 30 24 23
EBITDA, % 16.2 13.7 14.8 16.8 14.9 13.4 13.7 12.5 13.1 10.3 12.6
EBITA2) 35 29 118 37 31 24 26 91 25 21 20
EBITA, %
Operating cash flow
14.2
36
11.8
42
12.9
102
15.0
29
13.1
15
11.5
20
11.8
38
10.9
77
10.9
21
9.1
9
11.0
24
Net debt 480 496 526 526 541 538 538 569 569 578 496
Employees 1,405 1,425 1,435 1,435 1,355 1,360 1,375 1,370 1,370 1,370 1,240
Permobil (SEK m)
Sales 1,407 1,313 5,248 1,545 1,410 1,177 1,116 4,062 1,119 1,054 981
Sales growth, % 20 18 29 38 34 20 23 3 10 12 8
Organic growth, 13 9 9 17 12 0 6 6 6 11 18
constant currency, %
EBITDA
281 236 1,071 389 317 187 177 782 192 211 187
EBITDA, % 20.0 18.0 20.4 25.1 22.5 15.9 15.9 19.2 17.2 20.1 19.0
EBITA2) 230 185 880 335 266 145 133 612 149 168 147
EBITA, % 16.3 14.1 16.8 21.7 18.9 12.3 12.0 15.1 13.3 16.0 15.0
Operating cash flow 201 178 435 252 182 13 -13 214 37 90 -12
Net debt 3,735 3,610 3,330 3,330 3,752 3,568 3,388 3,166 3,166 3,026 2,959
Employees 1,830 1,805 1,805 1,805 1,780 1,755 1,755 1,660 1,660 1,645 1,630
Advanced Instruments (USD m)
Sales 37 34 134 35 35 33 31 103 31 26 24
Sales growth, %
Organic growth,
12 8 31 13 33 41 44 34 45 33 49
constant currency, % -1 -9 7 -5 3 16 20 24 18 26 47
EBITDA 16 12 45 11 12 8 14 38 12 3 12
EBITDA, % 42.7 36.0 33.6 32.1 35.9 22.7 44.3 37.1 37.1 13.3 50.9
EBITA2) 15 11 43 11 12 7 13 37 11 3 12
EBITA, % 40.7 34.0 32.1 30.6 34.3 21.3 42.8 35.7 35.8 11.9 49.5
Operating cash flow
Net debt
16
229
7
237
35
206
7
206
16
206
8
208
5
192
32
195
10
195
7
203
9
142
Employees 325 355 370 370 370 350 225 225 225 225 145
Piab (SEK m)
Sales 789 720 2,450 661 620 619 551 1,738 472 438 422
Sales growth, % 27 31 41 40 42 47 36 14 8 25 23
Organic growth, 4 12 11 7 6 17 17 18 8 26 33
constant currency, %
EBITDA
EBITDA, %
222
28.2
205
28.5
619
25.2
122
18.4
163
26.2
173
27.9
161
29.3
485
27.9
109
23.1
130
29.6
126
29.8
EBITA2) 193 181 530 97 139 152 142 409 81 113 110
EBITA, % 24.5 25.1 21.6 14.7 22.4 24.5 25.9 23.5 17.2 25.9 26.0
Operating cash flow 199 114 411 113 138 102 58 376 79 106 104
Net debt 3,097 2,952 2,431 2,431 2,591 2,423 1,986 1,767 1,767 1,505 1,548
Employees 1,185 1,160 1,030 1,030 1,020 995 875 695 695 680 660

INVESTOR Q2 2023 – 33

Q2 Q1 FY Q4 Q3 Q2 Q1 FY Q4 Q3 Q2
2023 2023 2022 2022 2022 2022 2022 2021 2021 2021 2021
BraunAbility (USD m)
Sales 288 250 929 242 252 211 224 692 184 192 171
Sales growth, % 36 12 34 32 31 24 53 22 22 26 86
Organic growth, 36 11 28 25 28 19 43 17 14 17 81
constant currency, %
EBITDA 37 33 86 24 23 17 22 52 13 17 12
EBITDA, % 12.9 13.1 9.3 9.9 9.3 8.1 9.8 7.5 7.2 9.0 7.1
EBITA2) 32 28 67 19 19 13 17 35 9 13 8
EBITA, % 11.1 11.1 7.2 7.7 7.5 5.9 7.7 5.1 4.6 6.6 4.9
Operating cash flow 24 0 46 14 19 3 9 38 8 23 6
Net debt 277 290 284 284 288 302 302 300 300 307 326
Employees 2,035 1,990 1,945 1,945 1,995 1,890 1,850 1,825 1,825 1,825 1,760
Vectura (SEK m)
Sales
82 84 302 78 74 75 74 279 71 61 66
Sales growth, % 9 13 8 9 23 14 -8 -6 -20 -21 -3
EBITDA 41 55 178 42 45 47 44 172 42 40 41
EBITDA, % 49.5 65.9 58.9 53.9 60.4 62.0 59.6 61.5 59.2 66.2 62.1
EBITA adjusted2) 4 23 50 10 13 15 13 45 7 13 13
EBITA, % 4.7 27.7 16.7 12.5 17.0 20.1 17.3 16.0 9.5 21.7 19.8
Operating cash flow -347 -351 -614 -160 -76 -252 -126 -355 -97 -52 -160
Net debt 5,901 5,679 5,223 5,223 4,984 4,376 4,343 3,963 3,963 3,453 2,537
Real estate,
market value 10,276 9,650 8,388
Employees 50 50 49 49 44 41 38 33 33 31 31
Atlas Antibodies (SEK m)
Sales 108 110 398 98 100 104 95 324 81 86 81
Sales growth, % 4 16 23 21 16 29 26 31 23 38 43
Organic growth, -6 7 14 9 7 21 20 34 19 39 47
constant currency, %
EBITDA
43 53 187 42 52 48 45 162 42 45 36
EBITDA, % 40.0 48.4 47.0 42.8 52.3 45.7 47.4 50.1 51.4 52.3 43.9
EBITA2) 36 46 165 36 46 42 40 143 37 40 31
EBITA, % 32.9 41.7 41.4 37.0 46.4 40.4 41.9 44.2 45.0 46.5 38.1
Operating cash flow 36 28 94 17 45 18 14 115 24 56 13
Net debt 338 372 342 342 352 391 403 406 406 429 22
Employees 120 120 130 130 120 120 120 115 115 110 115
Three Scandinavia
Sales, SEK m 3,004 3,021 11,834 3,283 3,025 2,798 2,728 10,750 2,925 2,696 2,543
Sweden, SEK m 1,908 1,911 7,668 2,160 1,942 1,817 1,749 6,946 1,929 1,740 1,617
Denmark, DKK m 708 744 2,904 756 755 700 694 2,787 730 697 676
EBITDA, SEK m 989 868 3,729 973 948 917 891 3,535 931 892 849
Sweden, SEK m 716 666 2,732 706 695 675 656 2,564 636 662 625
Denmark, DKK m 177 136 694 180 176 172 167 711 216 168 164
EBITDA, % 32.9 28.7 31.5 29.7 31.3 32.8 32.7 32.9 31.8 33.1 33.4
Sweden 37.5 34.8 35.6 32.7 35.8 37.2 37.5 36.9 33.0 38.1 38.6
Denmark 24.9 18.3 23.9 23.8 23.3 24.6 24.0 25.5 29.6 24.1 24.2
Net debt, SEK m 7,491 7,323 7,294 7,294 6,969 6,731 6,406 6,498 6,498 5,940 6,070
Employees 1,790 1,800 1,790 1,790 1,765 1,715 1,735 1,735 1,735 1,685 1,775

1) For information regarding Alternative Performance Measures in the table, see page 18. Definitions can be found on Investor's website.

2) EBITA is defined as operating profit before acquisition-related amortizations.

Valuation methodology
Listed Companies Share price (bid) for the class of shares held by Investor, with the exception of Saab, Electrolux and
Electrolux Professional for which the most actively traded share class is used.
Ownership calculated in accordance with the disclosure of regulations of Sweden's Financial Instruments
Trading Act (LHF). ABB, Accelleron, AstraZeneca, Nasdaq and Wärtsilä in accordance with Swiss, British,
U.S. and Finnish regulations.
Includes market value of derivatives related to investments if applicable.
Patricia Industries
Subsidiaries Reported value based on the acquisition method. As supplementary information, subsidiaries are also
presented at estimated market values, mainly based on valuation multiples for relevant listed peers and
indices. Other methodologies may also be used, for example relating to real estate assets. New investments
valued at invested amount during the first 18 months following the acquisition.
Partner-owned investments Reported value based on the equity method. As supplementary information, partner-owned investments are
also presented at estimated market values, mainly based on valuation multiples for relevant listed peers and
indices.
Financial Investments Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid).
Investments in EQT Unlisted holdings at multiple or third-party valuation, listed shares at share price (bid).

Patricia Industries, overview of estimated market values

Supplementary information In addition to reported values, which are in accordance with IFRS, Investor provides estimated market values
for the wholly-owned subsidiaries and partner-owned investments within Patricia Industries in order to
facilitate the evaluation of Investor's net asset value. This supplementary, non-GAAP information also
increases the consistency between the valuation of Listed Companies and our major wholly-owned
subsidiaries and partner-owned Three Scandinavia.
Estimated market values While the estimated market values might not necessarily reflect our view of the intrinsic values, they reflect
how the stock market values similar companies.
Methodology The estimated market values are mainly based on valuation multiples (median), typically Enterprise value
(EV)/Last 12 months' operating profit, for relevant listed peers and indices. We define EV as quarterly
volume-weighted average share price (VWAP) plus closing date net debt. While we focus on EBITA when
evaluating the performance of our companies, for valuation purposes, EBITDA multiples are more commonly
available, and therefore often used. From the estimated EV, net debt is deducted, and the remaining equity
value is multiplied with Patricia Industries' share of capital.
Adjustments Operating profit is adjusted to reflect, for example, pro forma effects of completed add-on acquisitions and
certain non-recurring items. An item is only viewed as non-recurring if it exceeds a certain amount set for
each company, is unlikely to affect the company again, and does not result in any future benefit or cost.
Acquisitions made less than 18 months ago are valued at cost.

Investor in brief

Investor, founded by the Wallenberg family in 1916, is an engaged owner of high-quality, global companies. We have a long-term investment perspective. Through board representation, as well as industrial experience, our network and financial strength, we work continuously to support our companies to remain or become best-in-class. Our holdings include, among others, ABB, Atlas Copco, Ericsson, Mölnlycke and SEB.

Our purpose

We create value for people and society by building strong and sustainable businesses.

Our ultimate target

Our ultimate target is to generate an attractive total return. Our long-term return requirement is the risk free interest rate plus an equity risk premium, in total 8-9 percent annually.

Our strategic priorities

Grow net asset value

We own high-quality companies and are an engaged owner, supporting our companies to achieve profitable growth. We strive to allocate our capital wisely.

Pay a steadily rising dividend

Our goal is to pay a steadily rising dividend. Our dividend policy is supported by cash flow from all three business areas: Listed Companies, Patricia Industries and Investments in EQT.

Deliver on our ESG targets

We firmly believe that sustainability integrated in the business model is a prerequisite for creating long-term value. Our three focus areas with specific targets are Business Ethics & Governance, Climate & Resource Efficiency and Diversity & Inclusion.

Our operating priorities

  • Engaged ownership
  • Ensure an attractive portfolio
  • Operate efficiently
  • Maintain financial flexibility

Talk to a Data Expert

Have a question? We'll get back to you promptly.